1. Home
  2. HBIO vs REFR Comparison

HBIO vs REFR Comparison

Compare HBIO & REFR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harvard Bioscience Inc.

HBIO

Harvard Bioscience Inc.

HOLD

Current Price

$7.93

Market Cap

26.5M

Sector

Industrials

ML Signal

HOLD

Logo Research Frontiers Incorporated

REFR

Research Frontiers Incorporated

HOLD

Current Price

$0.46

Market Cap

21.6M

Sector

Miscellaneous

ML Signal

HOLD

Company Overview

Basic Information
Metric
HBIO
REFR
Founded
1901
1965
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Multi-Sector Companies
Sector
Industrials
Miscellaneous
Exchange
Nasdaq
Nasdaq
Market Cap
26.5M
21.6M
IPO Year
2000
1995

Fundamental Metrics

Financial Performance
Metric
HBIO
REFR
Price
$7.93
$0.46
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$18.00
N/A
AVG Volume (30 Days)
19.3K
96.3K
Earning Date
05-12-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$116,176,000.00
$1,488,642.00
Revenue This Year
$4.77
N/A
Revenue Next Year
$8.55
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.38
$0.35
52 Week High
$7.90
$2.70

Technical Indicators

Market Signals
Indicator
HBIO
REFR
Relative Strength Index (RSI) 78.01 48.58
Support Level $5.91 $0.40
Resistance Level N/A $0.52
Average True Range (ATR) 0.32 0.04
MACD 0.12 0.01
Stochastic Oscillator 100.00 53.63

Price Performance

Historical Comparison
HBIO
REFR

About HBIO Harvard Bioscience Inc.

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, products, and services that enable advances in life science applications, including research, drug and therapy discovery, bioproduction, and preclinical testing. The company organizes its product line into two product families: Cellular and Molecular Technologies (CMT) and Preclinical. The CMT product family supports molecular, cellular, organ, and organoid research, as well as bioproduction and in vitro testing, while the Preclinical product family provides products for preclinical research and testing, including data collection and analysis for safety and regulatory compliance. Its geographical segments include the Americas, Europe, Middle East and Africa, and Asia.

About REFR Research Frontiers Incorporated

Research Frontiers Inc is engaged in the development and marketing of technology and devices to control the flow of light. The company develops and licenses its patented suspended particle device light-control technology to other companies that manufacture and market the SPD-Smart chemical emulsion, the light-control film made from the chemical emulsion, the light-control panels made by laminating the film, electronics to power end-products incorporating the film, or lamination services for, and the end-products. The company's revenue source comes from the licensing of technology.

Share on Social Networks: